Furthermore, we find that E,u stimulates recombination when located either upstream or downstream of SFL but that the position of the recombinational activator does affect the targeting of recombination junctions, suggesting that the relatively imprecise targeting of switch junctions in vivo may reflect the availability of many potential activator sites within each switch region.
Immunoglobulin isotype switch recombination is a regulated recombination event which joins an expressed heavychain variable [V(D)J] region to a new downstream constant (C) region, deleting the DNA between (for reviews, see references 5, 6, and 8) . Isotype switching occurs in B cells which have accomplished V(D)J joining and have been activated by antigen. Recombination involves G-rich switch or S regions, from 1 to 8 kb in length, which are found in the intron upstream of each C region that undergoes switching-C,u, Cy, Ca, and Ce; expression of Ca is regulated by alternative splicing, not recombination, and there is no G-rich S region upstream of Ca. In contrast to V(D)J joining, in which heptamer-nonamer recognition elements precisely target recombination (13) , switch recombination is notably imprecise. No conserved sequences comparable to the heptamer-nonamer elements are apparent within S regions or at switch recombination sites, and chromosomal switch junctions produced in vivo are heterogeneous with regard to both the site of recombination within each S region and the sequence at the recombination junction itself. Switch recombination is therefore region specific but not site specific, and the absence of site specificity suggests that switch recombination might depend at least in part on components involved in general cellular processes of recombination and/or repair.
The mechanisms which regulate and effect switch recombination are not well understood. We have developed a transient recombination assay that uses extrachromosomal substrates carrying immunoglobulin heavy-chain switch region sequences to study sequences and regulatory elements that may be important to isotype switching (19) . The substrates consist of a shuttle vector carrying S,u and Sy3 sequences flanking a conditionally lethal marker, the leftward promoter of phage A (APL). Substrates are transfected into primary murine spleen cells cultured with lipopolysaccharide (LPS) to induce switch recombination, low-molecular-weight DNA is recovered 40 h later, and recombination is assayed as deletion of the XPL region. When we first described this assay, we demonstrated that efficient recombination required the presence of S-region sequences and that an enhancer-promoter upstream of S,u stimulated recombination 12-fold, so that about 25% of recovered, replicated molecules had recombined during transfection of the eukaryotic cells. Both the immunoglobulin heavy-chain enhancerpromoter (Ep.PH) and the cytomegalovirus IE1 enhancerpromoter (EPCMv) stimulated recombination in the substrates.
Here we show that substrate recombination is threefold more efficient in LPS-cultured primary B cells than in the murine T-cell thymoma line EL4. MATERIALS AND METHODS Recombination substrates. pHL22 and pHL122 have been described previously (19) and are diagrammed in Fig. 1 . Briefly, pHL22 carries 2.2 kb of S,u sequence and 2.7 kb of S-y3 sequence flanking XPL, cloned into a shuttle vector consisting of the polyomavirus early region (for replication in murine B cells) and the origin of replication and ampicillin resistance (Ampr) gene of pBR322 (for replication and selection in Eschenchia coli). In pHL122, the immunoglobulin heavy-chain intron enhancer (Epu) and a minimal heavychain promoter (PH) are just upstream of the S,u region. pHL322 and pBHL322B, carrying E,u in forward and reverse orientations, respectively, were constructed by insertion of the 682-bp E,u XbaI-EcoRI fragment into XhoI and NotI sites in a short polylinker upstream of S,u in pHL22. (To simplify terminology, we will use "upstream" and "downstream" to describe positions with respect to direction of transcription in the genome, without implying that a sequence is itself transcribed, and "forward" and "reverse" to describe orientation with genomic orientation as the reference.) pK116, pK117, pK118, and pK119 carry E,u regions mutated at specific protein binding sites inserted in forward orientation upstream of S,u. Mutant enhancers 16 to 19 (18) were used to generate pK116 to pK119. Enhancers were PCR amplified from constructs generously supplied by T. Kadesch, using primers which annealed at the EcoRI and XbaI sites which define the boundaries of the enhancer; XhoI and NotI recognition sequences had been incorporated into the 5' and 3' primers, respectively, to permit directional cloning into the XhoI and NotI sites just upstream of S,u in pHL22. pBHL352, carrying E,u in forward orientation downstream of S,u, was generated by cloning the Ep, fragment into the BsaBI site at position -67 Of XPL; this destroys one of the three X repressor binding sites (the most promoter distal) but does not interfere with the genetic selection. pCMV152 was generated by inserting EPCMV at this same BsaBI site.
Transfection. Transfection of primary murine splenocytes has been described in detail previously (19) . Briefly, cells were cultured at 106 cells per ml in RPMI 1640 medium supplemented with 10% fetal bovine serum and 40 ,ug of LPS per ml. After 3 days in culture, 5 x 107 washed cells were transfected with 10 to 20 p,g of DNA in 100 p,g of DEAEdextran per ml. For transfection of ELA, a T-cell line derived from a murine thymoma, 107 washed cells were incubated at room temperature for 20 min with 10 p,g of DNA in RPMI 1640 containing 500 ,ug of DEAE-dextran per ml, washed twice, and cultured at 2 x 105 cells per ml. Transfection protocols for both cell types were optimized by using a VOL. 14, 1994 on Reporter constructs and expression assays. To construct pIgEPl-CAT, EpUPH was subcloned from pUC-IgEPV (19) into the EcoRV site of the Bluescribe KS+ polylinker (Stratagene) to generate pBP-IgEP, excised byXbaI-HindIII digestion, and inserted (by using an XbaI linker) into the AccI-HindIII sites of pSV2CAT (12) , so that ERUPH replaced the simian virus 40 early enhancer-promoter upstream of the CAT gene in the reporter construct. To construct pIgE-CAT, PH was deleted from pBP-IgEP by BamHI digestion and recircularization, and E,u was excised and inserted into the AccI-HindIII sites of pSV2CAT as described above for pIgEPl-CAT. DEAE-dextran transfection was carried out as described previously (19) . Whole cell extracts were prepared 48 h after transfection and assayed for CAT activity (12) .
Extrachromosomal switch recombination assay. The switch recombination assay has been described in detail previously (19) . Briefly, low-molecular-weight DNA was prepared from transfected cells 40 h after transfection, mixed with a small amount of the compatible plasmid pACYC184, which carries a chloramphenicol resistance (Cmr) marker and served as an internal transformation control, and digested with DpnI to destroy molecules that had not replicated in the eukaryotic cells. Equal aliquots of DNA were then electroporated into E. coli DH1OB and the isogenic X lysogen DH1OB(A). The recombination frequency, R, was calculated as the fraction of ampicillin-resistant colonies produced by transformation of the nonlysogen compared with the lysogen, normalized for any slight differences in transformation efficiencies of the two strains:
Control experiments have addressed the following critical points. (i) The S-region sequences in these constructs are not preferential sites for deletion in E. coli. We have assayed mutation of XPL following extensive propagation of a variety of constructs in E. coli and have found this mutation frequency to be <2 x 10-5 in all constructs examined.
Furthermore, in contrast to the deletions that occur during transfection of activated primary B cells, essentially all mutations that occur during propagation in E. coli consist of point mutations or deletions so small that they do not affect the restriction map. (ii) The genetic selection does not bias the assay. We assayed recombination frequencies by hybridization of a APL probe to transformants of DH1OB(X) and found these measurements to be comparable to those produced in the genetic assay. (iii) Deletion of XPL does not enhance replication of the shuttle vector in the mammalian cells. Constructs carrying and lacking XPL display comparable levels of replication during transfection. (iv) Deletion endpoints are heterogeneous and distinct from bacterial deletion endpoints. Both mapping and sequencing (see below) showed that sites in the constructs are not functioning as hotspots for deletion in the mammalian cells. Furthermore, regions of homology of 4 to 6 nucleotides (nt) or more characterize deletion junctions in multicopy plasmids in bacteria (15, 41) , and such regions are not found in recombinants of the switch substrates.
Mapping and sequencing of recombinants. Minipreps of recombinant DNA were prepared by a standard alkaline lysis protocol. Deleted regions in the recombinant plasmids were mapped by digestion with HindIII, BamHI, or EcoRI.
Recombinants were sequenced in chain termination reactions by using the following primers complementary to sequences within S,u: ,u85 (5'-CCCGGATCCACATGCTC TGTGTGA), ,l105 (5'-TCCCTCTGGCCCTGCTTATTGTT GAA), ,u414 (5'-TTAGGGGGAGAAAGAGAC), and 41072 (5'-ACTAACTCTCCAGCCACA). Figure 1 shows some of the extrachromosomal substrates used in the transient recombination assay. A shuttle vector carries S,u and S-y3 switch region sequences flanking a conditionally lethal marker, XPL. These plasmids can be propagated in strains of E. coli lysogenic for bacteriophage X, in which the endogenous cI repressor shuts off XPL transcription, but the high level of transcription driven by XPL interferes with plasmid replication in nonlysogenic strains of E. coli. The frequency of recombination events that remove XPL can therefore be assayed by comparing transformation of isogenic nonlysogenic and lysogenic strains of E. coli.
RESULTS
Previously we observed that following transfection of primary murine B cells, 2.1% of replicated pHL22 substrates had undergone recombination that deleted XPL and that an active enhancer-promoter placed upstream of S,u stimulated recombination 10-to 12-fold (19 activator sequences contribute to the observed recombination. Restriction mapping of recombination products showed that they carried a heterogeneous array of deletions that span XPL (data not shown), as do substrates that have recombined in activated primary B cells.
These data show that substrate recombination is about threefold more efficient in activated primary B cells than in the T-cell line. Most of the recombination that we observe is therefore likely to be due to activities that are unique to or enhanced in activated primary B lymphocytes. Is it surprising to find any recombination of the substrates during transfection of T cells? Only B cells have been shown to carry out regulated chromosomal switch recombination in vivo, but this does not mean that the enzymatic apparatus responsible for switch recombination is restricted to B cells. In fact, as considered in greater detail in Discussion, much of the control on chromosomal switch recombination may well depend on locus-specific regulation rather than a cell-typerestricted enzymatic apparatus. E,u alone can stimulate recombination. Our previous experiments showed that the recombination frequency of pHL122, which carries ERPH upstream of S,u, is 25.6%. This is dramatically higher than the recombination frequency of 2.1% observed with pHL22, which lacks these transcriptional regulatory sequences, or the recombination frequency of 1.2% observed with pHL422, which carries PH alone upstream of S,u (19) . To determine whether the high level of recombination observed with pHL122 correlates with transcription, we measured recombination of two constructs which lacked the promoter and carried E1 alone upstream of Sp, in either orientation. As shown in Table 2 , substrate pHL322, with ER in its natural orientation, recombined at a frequency of 24.1%, and pBHL322B, with E,u in the reverse orientation, recombined at a frequency of 17.7%. E,u alone can therefore stimulate recombination as well as EI±PH can.
To verify that removal of PH did in fact depress transcription in primary LPS-stimulated B cells, we compared expression of a reporter gene in constructs carrying E,U alone or ERPH as a transcriptional regulatory element. Figure 2 shows that expression of the CAT reporter gene was at least 50-fold lower in the construct carrying Ep. alone than in the construct carrying EP.PH-We also attempted to assay tran- would therefore probably be extremely short-lived in the cell. Effect of mutation in E,u on recombinational activation. To determine which elements within E,u can stimulate recombination of the extrachromosomal substrates, we constructed substrates carrying mutations in either or both of the functional domains of E,u. Mutant E,u regions (18) (a generous gift of T. Kadesch) were cloned upstream of S,u in the switch substrates to produce constructs that carry linker substitutions at the core, E4, and oct sites (pK117), at the core, El, E2, and E3 sites (pK118), or at all six sites (pK119). The mutations in the E,u regions of pK117 and pK118 diminish their transcriptional enhancer activity in the plasmacytoma P3-X63Ag8 to 80 and 20%, respectively, of the level of the normal enhancer, while the six mutations in the E,u region of pK119 render this element essentially inactive, reducing activity to 2% of the level of the normal enhancer (18) . The E,u region functions not only as an enhancer but also as a weak promoter, which drives reporter gene expression about 1% as well as EILPH does in the plasmacytoma P3-X63Ag8; this promoter activity of E,U is reduced 10-fold by the mutations of the E4 and oct binding sites in pK117 (29) .
Each of the enhancer derivatives in pK117-119 carries a linker insertion at a core site; the three reiterated core sites, Cl, C2, and C3, interact with a general factor, and core site mutation does not affect transcription in B cells (17) . As a reference construct, we therefore generated a substrate, pK116, which carries a linker insertion at a core site but is not mutated at the El, E2, E3, E4, or oct binding site. Recombination of pK116 was compared with recombina- tion of pHL322, which carries an unmutated E,u region. As shown in Table 3 , the core mutation in the E,u region of pK116 appears to diminish recombinational activation slightly: the recombination frequency of pK116, the reference construct, was 16.2%, or about 65% of the recombination frequency of pHL322, which carries an intact core region.
We compared recombination of constructs pK117, pK118, and pKll9 with that of the reference construct, pK116. As shown in Table 3 , the recombination frequency of pK117, mutated at the core, E4, and oct sites, was 9.0%, and the recombination frequency of pK118, mutated at the core, El, E2, and E3 sites, was 12.4%. The recombination frequency of pK119, in which the Epu region is mutated at the core, El, E2, E3, E4, and oct sites, was 1.9%, comparable to that of pHL22, which has no E,u or PH region. E,u-dependent stimulation of recombination therefore does require protein binding to the regulatory element. In the immunoglobulin heavy-chain locus, E,u is located just upstream of S,u in the J-C intron, and it is possible that E,u functions as a recombinational enhancer for isotype switching in vivo.
The ability of the regulatory element to stimulate recombination in the switch substrates appears to be essentially independent of its ability to stimulate transcription. Removal of the promoter from Ep.PH decreased transcription (as measured by expression) 50-fold or more but did not affect recombination (compare pHL122 and pHL322), and a further 10-fold decrease in the promoter activity of E,u by mutation of the E4 and oct binding sites diminished recombination only about 2-fold (pK117). A 500-fold decrease in transcription thus had only a 2-fold effect on recombination. This result suggests that the mechanism by which E,u stimulates recombination either does not depend, on transcription or is insensitive to the actual level of transcription over a broad range.
Transcriptional regulatory elements enhance recombination whether upstream or downstream of Sii. Ep. and EPCMV were tested for recombinational activation when inserted downstream rather than upstream of Sp.. Table 4 shows that the Transcriptional regulatory elements appear to target recombination endpoints. To determine whether the position or activity of the activator element might affect junction targeting, we mapped deletion endpoints in recombinants recovered from transfection of LPS-cultured primary murine B cells. Table 5 shows that in recombinants of substrates in which the regulatory element is between S,u and XPL, the majority of upstream endpoints mapped within Sp,: 89% of pBHL352 recombinants and 88% of pCMV152 recombinants. Furthermore, we found that in constructs in which the enhancer is located downstream of Sp,, not only did the majority of junctions map within Sp,, but about three times as many junctions were evident in the enhancer-proximal restriction fragment as would be predicted from size considerations alone (data not shown). In contrast, in constructs which carry a functional regulatory element upstream of S,u (pHL122, pHL322, and pCMV122), the regulatory element was frequently deleted during recombination, and in only a minority of these recombinants did endpoints map within Sp,: 22% of pHL122 recombinants, 38% of pHL322 recombinants, and none of the pCMV122 recombinants. Deletion of the regulatory element correlated with factor binding. In most recombinants of pKll9, which carries upstream of S,u an E,u region mutated at the C2, El, E2, E3, E4, and oct sites and undergoes recombination at very low levels, upstream junctions mapped within the Sp, region (67%). These results suggest that binding of regulatory factors may define a boundary of the recombination zone.
The results in Table 5 show that targeting of recombination in the switch substrates is strikingly dependent on the position and activity of the regulatory element. If so, the regulatory factors that bind the polyomavirus sequences downstream of the Sy3 region to direct shuttle vector replication may also affect junction targeting, and this may explain why in some cases (pCMV152, pHL122, and pTK119), over 80% of downstream junctions map in the S-y3 region, while in others (pBHL352, pHL322, and pCMV122), only about half the downstream junctions are within Sy3 and the rest are 3' of Sy3, within the polyomavirus sequences. However, it is also important to note that chromosomal switch junctions frequently map outside of S-region sequences. A recent compilation of chromosomal switch junctions shows that while essentially all downstream junctions map within the G-rich repetitive S-region sequences, about 40% of upstream junctions map not within but upstream of the S,p region (7). The significance of these upstream junctions in chromosomal switch recombination is currently unresolved: junctions outside Sp, occur frequently and are stably maintained during cell passage, suggesting that they are primary products of switch recombination, but they are not observed in certain data sets, particularly the circles that are produced as apparently reciprocal products of switch recombination in primary cells cultured with lymphokines and LPS (see reference 7 for a discussion). The junctions in the switch substrates that map outside of S-region sequences may therefore be analogous to some of the chromosomal recombinants observed in vivo, or they may reflect the design of these particular substrates.
Recombination junction sequences. Recombination junctions in two classes of recombinants were sequenced to determine whether recombinants were simple deletions and whether there were obvious hotspots for recombination, particularly when recombination involved sequences outside of the S regions. In a major class of pCMV152 recombinants, upstream endpoints mapped within the first few hundred bases of Sp,; Fig. 3A shows sequences of seven such pCMV152 recombinant junctions, three of which joined Sp, and Sy3 sequences and four of which joined Sp, to sequences downstream of Sy3. There appears to be no sequence preference or targeting at the recombination site. Four share no common sequences between the upstream and downstream recombination partners at the junction, and three share 1 to 4 nt of sequence identity. One recombinant, pRCMV152.25, has a 4-nt untemplated addition at the junction; additions of 1 to 33 nt are also observed at switch junctions, where they are typically composed of G-rich DNA that is similar but not identical to S-region sequence.
Sequences of four recombinants derived from pHL122 are also shown in Fig. 3 ; all of these sequences display limited (2 and 4 nt) identity between upstream and downstream sequences involved in recombination. The S-y3 region consists of about 40 reiterations of a consensus repeat 49 nt in length (30) , and two of the S-y3 recombination junctions mapped to repeat 33 in the germ line S-y3 region (pRHL122.3 and pRBHL122.15), but neither mapping nor sequence analysis thus far shows any consistent recombinational targeting in the substrates. Short (1-to 4-nt) regions of sequence identity were apparent at the recombination junction in 6 of 11 extrachromosomal substrates. Switch recombination is region specific, not site specific, and while chromosomal junction sequences do not bear any unique hallmark of the switch recombination apparatus, about half of the chromosomal products of chromosomal switch recombination do carry identities of 1 to 4 nt at the junctions (7) . Although the sequences do not prove that enzymes involved in switching have produced these junctions, they are certainly most consistent with this possibility. Short (25) and at junctions in Saccharomyces cerevisiae produced by recombination between similar but not identical DNA sequences, for example, divergent alleles of a single gene (homeologous sequences) (22) . This similarity is consistent with the possibility that some of the same or very similar enzymes carry out switch recombination and nonhomologous recombination.
Switch substrate junction sequences contrast with the pattern of spontaneous deletions in bacteria, in which sequence identity appears to be essential to the recombination mechanism. Studies of spontaneous deletions on the E. coli chromosome (2) and multicopy plasmids (15, 41) showed that the majority of deletions occur at sites with identity of 4 to 6 nt or longer, and deletions between sequences with no identity were rarely recovered. This finding further establishes that recombination of the substrates occurs during transfection of the eukaryotic cells, not during transformation of E. coli.
DISCUSSION
We have studied recombination of extrachromosomal substrates carrying immunoglobulin switch region sequences during transient transfection of primary B cells stimulated in culture to undergo chromosomal switch recombination. Previously we found that a functional promoter-enhancer upstream of the S,u region in these constructs could stimulate recombination 12-fold (19) . Here we show that the ability of the regulatory element to stimulate recombination does not correlate with its ability to stimulate transcript production. The immunoglobulin heavy-chain intron enhancer, E,u, stimulated recombination to the same high level alone or when combined with a minimal heavy-chain promoter: the 50-fold reduction in transcriptional activity associated with removal of the promoter had no effect on recombination. Furthermore, additional mutations at the E4 and oct sites in E,u that reduce the promoter activity of the isolated enhancer element 10-fold (29) resulted in only a 2-fold decrease in recombinational enhancement. Thus, a 500-fold reduction in transcription diminished recombination only 2-fold. Recombinational enhancement does depend on the presence of functional factor binding sites in Ep,, however, since an enhancer mutated at six separate binding sites cannot stimulate recombination.
Do the extrachromosomal substrates assay the same activities that carry out chromosomal switch recombination? To test cell type specificity, we assayed recombination of the switch substrates in the T-cell line ELA and found that recombination is about threefold more efficient in activated primary B cells than in the T-cell line. Most of the recombination that we observe is therefore likely to be due to activities that are unique to or enhanced in activated primary B lymphocytes. Nonetheless, we do observe a significant level of recombination in ELA (R = 7.1% for pCMV122). While this may be particular to the cell type or construct that we are using, it is also possible that the same enzymes that carry out switch region recombination in activated B cells participate in other recombination processes in other cell types.
Switch recombination in vivo is confined to a limited stage in B-cell development and could in principle require a recombination apparatus restricted to that cell type. However, no experimental evidence thus far has shown that this is the case. The cell type specificity of S-region-mediated recombination has been addressed in experiments that genetically assay the loss of a selectable marker from integrated retroviral constructs; in those experiments, recombination appeared to occur at a higher frequency in pre-B-cell lines than in a fibroblast line (23) . However, the validity of these experiments depends largely on the untested assumption that only a single copy of the retroviral construct was integrated in the derivative cell lines assayed. Moreover, recent genetic knockout experiments show that regulatory sequences must function in cis to stimulate switch recombination in activated B lymphocytes (16, 42 Our data show that recombinational stimulation in the switch substrates does require protein binding to the regulatory element, but recombination appears to be independent of transcript production. A temporal correlation between recombination and transcriptional activation has been documented both for isotypes switching and for V(D)J joining in mammalian lymphocytes, and Alt and coworkers have suggested that transcription could regulate recombination by rendering a region of DNA accessible to factors or lesions that promote recombination (3, 5, 21, 39) . However, there is considerable recent data suggesting that transcript production and recombination may not be mechanistically linked in mammalian cells. While culture with interleukin 4 induces sterile y1 and £ transcription in B lymphocytes, a second signal is necessary for induction of switch recombination (24) . Conversely, overproduction of the transcription factor E47 in a pre-T-cell line stimulates endogenous immunoglobulin D-J joining but not sterile transcription of the D-J region (26) ; and ,u heavy-chain expression in a pre-B-cell line stimulates K light-chain rearrangement independent of increased germ line K transcription (28) . These results are consistent with observations that V(D)J recombination in extrachromosomal substrates is independent of transcription through the recombination zone (14) . Homologous recombination between extrachromosomal substrates in mouse L cells similarly appears to be independent of transcription through the recombining regions (40) . In S. cerevisiae, in which recombinational activation has been studied in the greatest genetic detail, the HOT1 element has been shown to be identical with the rRNA promoter (31) , but while both the ARG4 and HIS4 recombinational hotspots in S. cerevisiae map very near promoters, there appears to be no correlation between transcription and recombination at either of these loci (27, 33) .
In the extrachromosomal switch substrates, factor binding but not transcription stimulates recombination. If there is no mechanistic link between recombination and transcription, why might transcription frequently correlate with recombinational activation at the chromosomal immunoglobulin loci? One possibility is that since transcription and recombination both involve alterations in chromatin structure and DNA architecture, transcriptional activation can occur as a by-product of recombinational activation. The prokaryotic integration host factor has been shown to act as either a recombinational or transcriptional activator (reviewed in reference 9), and both the prokaryotic transcription factor catabolite gene activator protein and the eukaryotic factor LEF-1 can substitute for integration host factor in A Intpromoted recombination in vitro (10, 11) . This functional interchangeability appears to also characterize some of the transcription factors that regulate the yeast HIS4 recombination hotspot (33) , and it may be a widespread property of proteins that regulate transcription or recombination.
The position of the regulatory element in the switch substrates affected the selection of recombination endpoints, and binding of protein factors therefore appears to target as well as stimulate recombination. This may have implications for targeting of chromosomal switch recombination. Our laboratory has identified an inducible DNA-binding and -bending protein, LR1, with multiple binding sites in each of the S regions (34) (35) (36) . Others (20, 32, 37, 38) have identified sites within the S regions for other factors, including another B-cell-specific factor, BSAP (1, 4), distinct from LR1 in both molecular weight and recognition sequence (34, 35) . This finding raises the possibility that binding site selection by regulatory factors could explain the apparently random distribution of switch junctions.
